Literature DB >> 31939787

Prevalence and Risk Factors for Thrombotic Complications Following Venovenous Extracorporeal Membrane Oxygenation: A CT Scan Study.

Gabriel Parzy1,2, Florence Daviet1,2, Nicolas Persico, Romain Rambaud1, Ugo Scemama3, Mélanie Adda1,2, Christophe Guervilly1,2, Sami Hraiech1,2, Kathia Chaumoitre3, Antoine Roch, Laurent Papazian1,2, Jean-Marie Forel1,2.   

Abstract

OBJECTIVES: The aims of this study were to: 1) analyze the cannula-associated deep vein thrombosis frequency after venovenous extracorporeal membrane oxygenation using a CT scan and 2) identify the associated risk factors for cannula-associated deep vein thrombosis.
DESIGN: Retrospective observational analysis at a single center.
SETTING: Tertiary referral university teaching hospital. PATIENTS: Patients under venovenous extracorporeal membrane oxygenation with a femorofemoral or femorojugular cannulation admitted for acute respiratory distress syndrome or primary graft dysfunction after pulmonary transplantation. CT scan was performed within 4 days after decannulation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We included 105 of 228 patients screened. Bacterial pneumonia was the main indication of venovenous extracorporeal membrane oxygenation (46.7%). CT scans were performed at a median of 2 days (1-3 d) after decannulation. Cannula-associated deep vein thrombosis was found in 75 patients (71.4%) despite it having a mean activated partial thromboplastin time ratio of 1.60 ± 0.31. Femorofemoral cannulation induced femoral cannula-associated deep vein thrombosis more frequently than femorojugular cannulation (69.2% vs 63.1%, respectively; p = 0.04). Seventeen of the 105 patients (16.2%) had a pulmonary embolism. Multivariate logistic regression analysis showed that higher the percentage of thrombocytopenia less than 100 G/L during extracorporeal membrane oxygenation period, lower the risk for developing cannula-associated deep vein thrombosis (hazard ratio, 0.98; 95% CI, 0.98-1.00; p = 0.02).
CONCLUSIONS: Cannula-associated deep vein thrombosis after venovenous extracorporeal membrane oxygenation is a frequent complication. This plead for a systematic vascular axis imaging after venovenous extracorporeal membrane oxygenation. Thrombocytopenia is associated with a reduction in the occurrence of thrombotic events.

Entities:  

Year:  2020        PMID: 31939787     DOI: 10.1097/CCM.0000000000004129

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study.

Authors:  Alexandre Mansour; Erwan Flecher; Matthieu Schmidt; Bertrand Rozec; Isabelle Gouin-Thibault; Maxime Esvan; Claire Fougerou; Bruno Levy; Alizée Porto; James T Ross; Marylou Para; Sabrina Manganiello; Guillaume Lebreton; André Vincentelli; Nicolas Nesseler
Journal:  Intensive Care Med       Date:  2022-07-13       Impact factor: 41.787

Review 2.  Anticoagulation in ECMO patients: an overview.

Authors:  Gaurav Kumar; Ashish Maskey
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-03-23

3.  Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation.

Authors:  Abhimanyu Chandel; Saloni Patolia; Mary Looby; Najeebah Bade; Vikramjit Khangoora; Christopher S King
Journal:  J Intensive Care Med       Date:  2021-03-01       Impact factor: 3.510

4.  Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19.

Authors:  Mathieu Jozwiak; Jean-Daniel Chiche; Julien Charpentier; Zakaria Ait Hamou; Paul Jaubert; Sarah Benghanem; Pierre Dupland; Ariane Gavaud; Frédéric Péne; Alain Cariou; Jean-Paul Mira; Lee S Nguyen
Journal:  Front Med (Lausanne)       Date:  2020-12-10

5.  Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.

Authors:  Joseph F Rappold; Forest R Sheppard; Samuel P Carmichael Ii; Joseph Cuschieri; Eric Ley; Erika Rangel; Anupamaa J Seshadri; Christopher P Michetti
Journal:  Trauma Surg Acute Care Open       Date:  2021-02-24

6.  Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients.

Authors:  Katherine Giuliano; Benjamin F Bigelow; Eric W Etchill; Ana K Velez; Chin Siang Ong; Chun W Choi; Errol Bush; Sung-Min Cho; Glenn J R Whitman
Journal:  Crit Care Explor       Date:  2021-07-13

7.  Risk Factors of Ischemic and Hemorrhagic Strokes During Venovenous Extracorporeal Membrane Oxygenation: Analysis of Data From the Extracorporeal Life Support Organization Registry.

Authors:  Sung-Min Cho; Joe Canner; Giorgio Caturegli; Chun Woo Choi; Eric Etchill; Katherine Giuliano; Giovanni Chiarini; Kate Calligy; Peter Rycus; Roberto Lorusso; Bo Soo Kim; Marc Sussman; Jose I Suarez; Romergryko Geocadin; Errol L Bush; Wendy Ziai; Glenn Whitman
Journal:  Crit Care Med       Date:  2021-01-01       Impact factor: 9.296

8.  Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.

Authors:  Gabriel Parzy; Florence Daviet; Basile Puech; Aude Sylvestre; Christophe Guervilly; Alizée Porto; Sami Hraiech; Kathia Chaumoitre; Laurent Papazian; Jean-Marie Forel
Journal:  Crit Care Med       Date:  2020-10       Impact factor: 9.296

9.  Heparin-Induced Thrombocytopenia in Severe COVID-19.

Authors:  Florence Daviet; Christophe Guervilly; Olivier Baldesi; Fanny Bernard-Guervilly; Estelle Pilarczyk; Adrien Genin; Laurent Lefebvre; Jean Marie Forel; Laurent Papazian; Laurence Camoin-Jau
Journal:  Circulation       Date:  2020-09-29       Impact factor: 29.690

10.  New-onset type 1 diabetes complicated by diabetic ketoacidosis and severe sepsis requiring extracorporeal membrane oxygenation and kidney replacement therapy.

Authors:  Nurul Aliah Mohd Asarani; Justine Paddison; Robert Walker; Michelle Downie; Benjamin J Wheeler
Journal:  J Diabetes Metab Disord       Date:  2021-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.